Stack
Reta-Cagri 5mg/5mg
Retatrutide + Cagrilintide
CAS: 2381089-83-2 / 2381089-29-0
$134.99$149.9910% OFFIn Stock
Reta-Cagri 5mg/5mg — Retatrutide (triple GLP-1R/GIPR/GcgR agonist) combined with Cagrilintide (amylin analog). Four independent receptor pathways for the most comprehensive metabolic research stack available. 98.5% HPLC purity.
Specifications
Retatrutide5mg
Cagrilintide5mg
FormLyophilized Powder
Purity98.5% HPLC
Storage-20C long-term
For laboratory research use only. Not for human consumption.
Mechanism of Action
Four-receptor co-stimulation: GLP-1R (appetite suppression) + GIPR (incretin potentiation) + GcgR (thermogenesis) from retatrutide, plus AMY1/AMY3 (brainstem satiety) from cagrilintide — all through non-overlapping mechanisms.
Research FAQ
How is Reta-Cagri different from Cagri-Reta?
Same compounds in the same 5mg/5mg ratio. The naming convention reflects the lead compound (Retatrutide vs Cagrilintide) but the peptide content is equivalent.
